Investigating how age-related changes in the eye's gel affect glaucoma treatment.
The impact of age-related vitreous degeneration and vitreous replacement on scleral biomechanics: a novel mechanism and treatment target for glaucoma
This study is looking at how changes in the jelly-like substance in the eye as we age might affect the outer layer of the eye, which is important for understanding glaucoma, and it hopes to find new ways to help manage this condition better for patients.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Alabama at Birmingham NIH-funded |
| Lab location | 1 site (Birmingham, United States) |
| Project ID | NIH-10836520 on NIH RePORTER |
What this research studies
This research explores the relationship between age-related degeneration of the vitreous gel in the eye and its impact on the biomechanics of the sclera, which is crucial for understanding glaucoma. By examining human donor eyes, the study aims to assess how changes in the vitreous affect the sclera's response to fluctuations in intraocular pressure. The goal is to identify new mechanisms that could be targeted for glaucoma treatment, potentially leading to improved management strategies for patients.
Who could benefit from this research
Good fit: Ideal candidates for this research are older adults who are at risk for or currently diagnosed with glaucoma.
Not a fit: Patients with glaucoma who are not experiencing age-related changes in their vitreous may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to innovative treatments that better manage glaucoma and reduce the risk of blindness.
How similar studies have performed: While the specific focus on vitreous degeneration in relation to scleral biomechanics is novel, previous studies have successfully explored other biomechanical factors in glaucoma treatment.
Where this research is happening
Birmingham, United States
- University of Alabama at Birmingham — Birmingham, United States (Active)
Researchers
- Principal investigator: Bianco, Gianfranco — University of Alabama at Birmingham
- Study coordinator: Bianco, Gianfranco
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.